Our in vitro models provide solutions for the preclinical screening of drug candidates in the number of cell-based systems derived from ocular tissues prior to transitioning to preclinical proof of efficacy in vivo models.
Experimentica Ltd. presents strategic roadmap and announces €3,05M investment in artificial intelligence for preclinical efficacy and safety testing of ophthalmic drug candidates
Experimentica Ltd. participates in ORBITAL, an EU Horizon 2020 Marie Sklodowska-Curie Innovative Training Network award
Subscribe to Our Newsletter!
We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!